NCT01845623View on ClinicalTrials.gov

A Study to Evaluate the Effects of Indacaterol Maleate (QAB149) as a New Formulation in the EPIC Test Fixture

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 31, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Asthma
Interventions
DRUG

QAB149 75 mg Concept 1

QAB149 delivered via the concept 1 device.

DRUG

QAB149 75 mg Epic Test Fixture

QAB149 delivered via the EPIC test fixture

OTHER

Placebo Concept 1

Placebo administered via the Concept 1 device.

OTHER

Placebo EPIC Test Fixture

Placebo administered via the EPIC Test Fixture.

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY